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Randomised control trial (RCT) methodology has compared interventions for prevention and management 
of dental caries since the late 1960s. Despite almost 50 years and evidence of significant wastage within 
the wider biomedical research field, there has been little investigation into what works well and where 
weaknesses lie. This paper summarises systematic review findings of cariology clinical trials, focussing on 
interventions and outcomes as two important areas within trial design and analyses. Examples illustrate 
some challenges with intervention delivery fidelity, outcome analyses and intervention co-production. 
Trial design stage choices are critical in ensuring optimum information is obtained when testing 
interventions.  Intervention choice, outcome choice and analyses are particularly important and cariology 
trials have specific issues associated with them. A systematic search and review of cariology RCTs, found 
650 RCT reports. Social Network Analysis of interventions revealed: a high degree of separation between 
prevention and management trials; gaps in clinically important comparisons; a tendency to compare within 
groups e.g. comparison of interventions within the same, rather than different, levels of invasiveness.  
Outcomes measured for the same trial reports show: a focus on restoration performance and 
individual/population caries burden; growing use of carious lesion activity and economic related outcomes; 
and sparse, although growing use of, patient-reported/ patient-centred outcomes. 
Fidelity of adherence to complex interventions can be challenging to measure but is important in 
interpreting trial findings. Involving target populations in intervention design, delivery and relating it to the 
planned rollout, are opportunities to ensure intervention relevance and improve uptake.  Outcomes’ 
analyses should consider minimum clinical important difference and outcome relevance for the target 
population. 
Factors underlying trialists’ comparator and outcome choice need to be identified, and there is a need to 
ensure that there is a minimum dataset of outcomes to allow combination and comparisons of trial data 
for systematic review. 
Keywords: dental caries, clinical studies/ trials, restorative dentistry, preventive dentistry 
Introduction 
The first controlled clinical trial, carried out by James Lind in 1747, investigated whether citrus fruit could 
treat the symptoms of scurvy (Trohler 2005).  It took a further 200 years, until 1948, before the first modern 
medical randomised controlled trial (RCT) was conducted (Crofton 2004) looking at Streptomycin for 
pulmonary tuberculosis (Yoshioka 1998). The RCT is considered the best way to test treatments. However, 
they are complex, expensive, time-consuming and difficult to carry out to a high standard.  The challenges 
in producing high quality, relevant and useful research are manifold (Heneghan et al. 2017). The RCT is 
often talked about as a single entity, however, it comprises various parts, each of which, at the design, 
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execution, evaluation and write up stage is subject to choices which can affect result of the trial or its 
interpretation.  Discussion and recommendations about methods to ensure a trial is successfully conducted 
have been more limited; for example, which methods within the RCT design are best in which situation 
(Ioannidis et al. 2014). It is ironic that there has been so little investigation into how to make trials as 
efficient and high quality as possible, leaving trial design and process lacking in a credible evidence-base. 
Two key points where decision making is critical are the areas of intervention choice and outcomes/ 
outcome measures’ selection and analyses (Heneghan et al. 2017).  
Clinical trials in cariology often do not have well-defined interventions and definite endpoints (Lamont et 
al. 2015). This paper will present some evidence on caries trials’ methodologies related to interventions 
and outcomes over the last 50 years, raise awareness of complexities of both intervention design/ 
implementation (Stamm 2004) and outcome choice, though the example of two large-scale UK NIHR 
funded clinical RCTs (FiCTION and BRIGHT) looking at the prevention and management of dental caries and 
carious lesions.  
Why does this matter? 
Ideally, evidence flows seamlessly from novel discovery to evaluation in several primary clinical trials (Innes 
et al. 2016), the results of which are synthesised into systematic reviews which then inform practice 
guidelines that are then translated, through practitioners’ daily care, into improved patient outcomes.  
However, the flow isn’t always smooth with significant inefficiencies and wastage in the business of 
evidence production (Macleod et al. 2014). Back in 1747, it took 42 years for James Lind’s work to translate 
into the Naval “Sick and Hurt Board” introducing citrus fruits to ships (Trohler 2005). Global life sciences 
research cost around US$240 billion in 2010. Furthermore, less than half of the biomedical literature that 
reaches the stage of publication is estimated to be of sufficient quality (in conduct and reporting) to be fit 
for purpose.  Overall wastage within the research system is around US$200 billion; around 85% of the initial 
investment (Chalmers and Glasziou 2009). The figure remains unquantified as a whole for oral and dental 
research but the same problem of poor quality trials and their reporting is well known (Fleming et al. 2014; 
Lucena et al. 2017; Pandis et al. 2014; Rajasekharan et al. 2015; Sandhu et al. 2015). There is no reason to 
believe that the relative magnitude of the problem of waste is likely to be different from the rest of the 
biomedical field. 
Clinical trials have long been categorised as either explanatory or pragmatic (Schwartz and Lellouch 1967).  
Explanatory trials tend to be undertaken to assess the efficacy of an intervention under optimised 
conditions whilst pragmatic trials aim to determine the relative effectiveness of interventions within the 
environment in which they are going to be applied. In reality, there is a continuum between the two 
extremes (Sedgwick 2014).  Pragmatically oriented trials have been increasing, supported by the desire to 
have evidence more likely to be translated to point of care.  In the US, UK, Germany, Holland and Japan 
successful primary care networks have been set up, with general or other non-academic practitioners 
taking a key part in the research. Efforts to improve the design and efficiency of cariology trials do not seem 
to have been taken forward (Blackwelder 2004; Featherstone 2004). 
Getting the choice of intervention and outcomes right 
To make informed choices between treatment options in the clinical encounter, it is necessary to have a 
complete picture of how all available interventions perform against one another. Furthermore, the 
outcomes that are studied should be relevant to patients, and they must be similar enough across trials to 
allow synthesis of the data, informing the evidence base (Heneghan et al. 2017).  If interventions are not 
compared to one another and similar outcomes are not measured, then it is not possible to synthesise the 
evidence.  To look more closely at these issues, within the field of prevention and management of dental 
caries, we carried out systematic reviews of all RCTs over the last 50 years.  Interventions and outcomes 
were categorised and analysed (Levey et al. 2016, Levey et al. 2017, Schwendicke et al. 2017). Structured 
searching elicited 4774 articles and after screening titles, abstracts then full papers, 605 reports of RCTs 
were catalogued. 
What do we investigate in cariology clinical trials? - Interventions 
The strength of the overall evidence in any area of healthcare is governed by the extent to which the full 
range of relevant comparators have been investigated across the whole network of trials. This involves not 
only the interventions themselves but the relative comparator choice of intervention X against intervention 
Y. However, clinical trial design is often arbitrary, driven by happenstance, individual preferences or 
assumed relevance. Within cariology, the changing field has been driven by discoveries of novel 
remineralizing and biofilm modulating agents, new materials, and new treatment technologies (sealing in 
dental caries, for example). However, the overall strength of the evidence and the gaps in the field remain 
difficult to determine.  Applying social network analysis, a mathematical modelling tool to evaluate the 
presence, strength or absence of relationships between the objects in the network (Rizos et al. 2011) 
allowed us to identify what has been investigated and helped clarify where gaps are. This revealed 
limitations in the evidence on the comparative effectiveness of caries prevention/management strategies 
(Schwendicke et al. 2017). Comparator choice seems to be driven by clinical indication (as might be 
expected). However, these limit conclusions on the true relative effectiveness of all strategies. There are 
still a variety of comparators that have not been, but should be, compared to one another. It also seems 
that comparisons within comparator classes (such as within various levels of invasiveness for the 
interventions) are preferred over comparisons between classes; for example, comparisons between Hall 
Technique crowns and standard restorations being preferred to comparisons of Hall Technique crowns 
with use of silver diamine fluoride. These choices might be clinically driven but they limit understanding of 
performance of the interventions compared to one another. 
What do we measure in cariology trials? – Choice of outcomes 
Inconsistent outcome reporting is a significant hurdle to combining results from trials into high quality 
systematic reviews (Ioannidis et al. 2017; Lamont et al. 2015). There is also the issue of selective outcome 
reporting resulting in bias, which is becoming acknowledged as a serious issue in medicine but has not yet 
been looked at in Dentistry (Ioannidis et al. 2017). Development and use of core outcome sets (COS) can 
reduce this barrier. A core outcome set is an agreed minimum set of outcomes that are included in the 
design of trials and allow data to be combined and compared at the systematic review stage. Our review 
of outcomes found a total of 1,364 outcomes reported in 605 published reports.  We mapped outcomes 
reported in caries prevention and management RCTs as a first step to COS development, using systematic 
review methodology.  Over the last 50 years, outcome reporting for clinical trials on prevention of caries 
and management of carious lesions have focussed on measuring “caries experience” and “restoration 
material clinical performance”, with “lesion activity” and “cost-effectiveness” increasingly being reported 
in more recent studies. Patient-reported and patient-focussed outcomes are becoming more common (as 
secondary outcomes) but remain low in use. The challenge with developing a COS will be anticipating 
outcomes relevant for the future based on trends from the past. 
Examples of some challenges with intervention delivery fidelity, outcome analysis and intervention co-
production are given in the following sections. Using two ongoing clinical trial, illustrations of the, 
sometimes hidden and unacknowledged, complexities with RCTs are explored. 
 
FiCTION (Filling Children's Teeth: Indicated Or Not?) NIHR-HTA funded UK-wide trial 
FiCTION (https://www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/) is a multi-centre primary 
dental care child-level, open RCT to determine the most clinically- and cost-effective approach to managing 
caries in the primary dentition in the UK (Innes et al. 2013). The pilot trial began in 2009 (Marshman et al. 
2012) and the main trial began in 2012, involving 72 dental practices and 1,124 children with dentinal caries 
(3-7 years-old on enrolment). Children are randomised to receive one of three caries management 
strategies (in a 1:1:1 ratio) and followed up over three years (Keightley et al. 2014; Stewart et al. 2015). 
The management strategies being used mean that it is not possible to blind the parents, children, or 
dentists as to which arm the child is participating in. 
FiCTION has been commissioned to inform practice, teaching and funding of children’s dentistry across the 
UK, with both quantitative and qualitative data incorporated within the outcomes.  The primary outcome 
is incidence of pain and/ or dental infection. Secondary outcomes are: incidence of caries in primary and 
permanent teeth; quality of life; acceptability of treatment experiences to children and parents; and 
dentists’ treatment preferences. The three treatment strategies for managing caries in the primary 
dentition are: 
Arm 1: Conventional management of decay, with best practice prevention: Carious lesions are managed 
based on active treatment of caries by its complete removal.  Local anaesthesia is placed, caries is 
mechanically removed using rotary instruments or by hand excavation and a restoration is placed. If the 
dental pulp is exposed during caries removal or there are symptoms of pulpitis, a pulpotomy may be carried 
out. Best practice prevention is carried out in line with current guidelines (see Arm 3). 
Arm 2: Biological management of decay, with best practice prevention: Carious lesions are sealed into 
the tooth and separated from the oral cavity by an adhesive filling material over the decay, or by covering 
the tooth with a preformed crown using the Hall Technique. Decay may, on occasion, be partially removed 
prior to the tooth being sealed. Injections are rarely needed. Best practice prevention is carried out in line 
with current guidelines (see Arm 3). 
Arm 3: Best practice prevention alone 
Control of the biofilm through its frequent removal and low sugar intake can slow down carious lesion 
progression. For the best practice prevention alone arm, no caries removal, restoration placement or 
carious lesion sealing of primary teeth takes place. Treatment plans are based on best practice preventive 
care according to current UK guidelines. For primary teeth this involves three strands: 
 Toothbrushing/ self-applied topical fluoride use; 
 Dietary investigation, analysis and intervention; and 
 Fluoride varnish application. 
 
FiCTION trial’s intervention delivery and adherence to protocol 
Interventions applied over long periods of time in more pragmatically oriented clinical trials often suffer 
from difficulties with adherence to protocol.  For FiCTION, monitoring how well practitioners had applied 
the three different trial arms over the three-year duration was important to be able to see where there 
had been drift or any “blurring” between arms. The direction and extent of deviations between arms is 
being monitored quantitatively through data collected from the dentists, explaining which arm the patient 
was moved to and why. This information will feed into the interpretation of the results by providing a basis 
for carrying out the intention to treat and the per protocol analyses. 
There is no direct guidance on the thresholds for insufficient adherence to protocol for the arms to have 
been sufficiently implemented as intended.  This is further complicated because each arm has multiple 
components.  Should all component parts of the arms contribute equally to an episode of deviation or 
should they be weighted? A final complexity is added by the varying levels of treatment that are required 
by the children in the trial. Within trials of medicinal products, the figure of 80% is often applied as a cut 
off for deciding on adherence if there is no rational basis for choosing a different figure. Because, clinically, 
this seemed reasonable, this has been taken as our cut-off for the FiCTION trial. A child having 21 tooth 
treatments throughout the trial with four teeth treated in a different arm will have had 81% adherence to 
the arm they were randomised to. However, if a child who only has one tooth treated in the trial has that 
single tooth treated away from arm, this is 0% adherence to protocol.  
The process evaluation (Moore et al. 2015) has a qualitative component to allow more in-depth analyses 
of these deviations which should help to inform the implementation of FiCTION and explain the deviations 
from treatment that are seen, as these are not uniform across practitioners or between arms. 
FiCTION trial’s primary outcome: pain and infection 
One of the biggest hurdles with trying to use clinical studies to underpin clinical decision making is that 
they often do not include thresholds of direct importance to patient care.  The minimal clinically important 
difference is the smallest difference between interventions that a patient or dentist would consider 
adequate when choosing to use a new intervention (Make 2007). 
At the start of the trial, the proposed primary outcome for FiCTION, was the proportion of children with at 
least one episode of dental pain and/or dental sepsis during the planned three year follow up period.  The 
individual components of this composite outcome were to be considered as having equal importance 
(Cordoba et al. 2010). The outcome was going to be dichotomized: zero episodes of dental pain/ sepsis or 
at least one episode. As the trial progressed it became clear that the number of episodes experienced by a 
child was a more clinically relevant outcome and statistically a more sensitive measure.  This was directly 
relevant to the minimal clinically important differences between the three treatment arms. The trial 
protocol was changed, re-appraised by the ethics committee and finalised as having co-primary outcomes 
through two analyses for the primary outcome data; 1) the proportion of children with at least one episode 
of dental pain and/or dental sepsis during the follow up period (incidence) using logistic regression, and 2) 
the total number of episodes of dental pain and/or dental sepsis for each child during the follow-up period 
using negative binomial regression.  Because the original power calculation for the trial was based on a 
comparison of proportions, it remains the only powered analysis; however, an exploratory hypothesis test 
for the unpowered comparison of the mean number of episodes will be carried out and reported. The 
outcome data from FiCTION will be reported and published in 2018/9. 
BRIGHT (Brushing RemInder 4 Good oral HealTh) NIHR-HTA funded UK-wide trial 
Dental caries affects one in three, UK 12 year-olds and is closely linked to deprivation. Brushing with 
fluoridated toothpaste is a highly effective preventive measure and early establishment of self-care 
operation is associated with improved oral health through the lifecourse (Broadbent et al. 2016). Mobile 
health (mHealth) multimedia technologies interface with health care delivery most commonly involving 
mobile phones and making it a potential vehicle for health behaviour change (Head et al. 2013) with 
short messaging service (SMS) interventions showing robust effects on behaviours and outcomes (Head et 
al. 2013; Fjeldsoe et al. 2009). BRIGHT 
(https://www.journalslibrary.nihr.ac.uk/programmes/hta/1516608/#/) will evaluate the clinical and cost-
effectiveness of a behaviour change programme to improve the oral health of young people living in 
deprived areas across the UK.  It is a multi-centre, school based, assessor-blinded, two-arm cluster-
randomised controlled trial with an internal pilot trial involving 5,760 young people (11-13 years-old). The 
BRIGHT intervention is a classroom-based, curriculum-embedded session and co-designed follow-up text 
messages, compared to routine education and no text messaging. 
The primary outcome is incidence of carious lesions in permanent teeth (at three years). Secondary 
outcomes are: self-report frequency of daily tooth brushing; clinical assessment of plaque/gingivitis; Cost-
effectiveness; and health- and oral health- related quality of life and oral health behaviours. 
BRIGHT trial’s intervention design 
In the BRIGHT Trial, the intervention was pre-specified by the funder as a classroom based session and a 
series of follow-up text messages.  The Keep on Brushing SMS programme, on which the funding call was 
based, had looked at unemployed 18-24 year olds in New Zealand (Schluter et al. 2015; Smith and 
Whaanga, 2015).  The content of those messages was not appropriate for UK 11-13 year-olds. We adopted 
a co-design approach to the content of the SMS by using young people’s own words, developed through 
the workshops to remind and reinforce the messages from the classroom based session.  The assumption 
before carrying out the workshops had been that young people would be interested in being similar their 
friends, mimicking celebrities and interested in health. These were then presumed to be the factors that 
would be incorporated into the text message prompts.  However, it became clear that the biggest factor 
that triggered interested in this topic was around avoiding disease rather than health and beauty; this was 
especially true when there was a “gory” part to the message, for example, one of the young people’s 
developed and favoured messages was “On a daily basis, 100 million micro-creatures are swimming, eating, 
reproducing and depositing waste in your mouth”. Designing interventions with the help of the target 
population can help to ensure the relevancy of it. 
Conclusion  
Although agreed as being a robust methodology for testing treatments, the RCT is expensive and 
acknowledged as being one of the most challenging to execute. Nevertheless, little attention has been paid 
to their design stage, and ensuring they are appropriate for use. Designing RCTs is a complex process that 
involves multiple stakeholders with multiple agendas. Decisions at the design and analyses stages will have 
a major impact on the quality and usability of the trial findings downstream. The designs of proposed 
clinical trials should be informed by evidence from the strengths and weaknesses of previous trials 
(Richards, 2011).  In addition, gaps in research evidence can only become clear through evaluating what 
has already been studied. Once identified, gaps in the scope of research and research methodology should 
be addressed. There must be conversations and coordination between the major funders, researchers and 
end users of the research to ensure that the right interventions and the right outcomes with minimal 
clinically important differences are investigated.  
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